Easterly Investment Partners LLC increased its holdings in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 13.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 100,702 shares of the real estate investment trust's stock after acquiring an additional 11,655 shares during the quarter. Easterly Investment Partners LLC owned about 0.22% of National Health Investors worth $7,061,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC increased its holdings in shares of National Health Investors by 15.8% in the first quarter. Allspring Global Investments Holdings LLC now owns 3,635 shares of the real estate investment trust's stock valued at $268,000 after purchasing an additional 495 shares during the last quarter. Bank of New York Mellon Corp grew its stake in National Health Investors by 5.6% in the 1st quarter. Bank of New York Mellon Corp now owns 588,871 shares of the real estate investment trust's stock valued at $43,494,000 after buying an additional 31,451 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in National Health Investors by 11.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 3,611 shares of the real estate investment trust's stock worth $267,000 after acquiring an additional 357 shares during the last quarter. SG Americas Securities LLC bought a new stake in shares of National Health Investors during the first quarter worth approximately $808,000. Finally, Sumitomo Mitsui Trust Group Inc. grew its position in shares of National Health Investors by 3.3% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 478,900 shares of the real estate investment trust's stock valued at $35,372,000 after purchasing an additional 15,497 shares during the last quarter. Institutional investors and hedge funds own 62.51% of the company's stock.
Wall Street Analyst Weigh In
Several research firms recently weighed in on NHI. National Bankshares set a $90.00 price target on National Health Investors in a report on Wednesday, October 1st. KeyCorp raised shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 target price for the company in a research report on Thursday, July 10th. Wedbush raised shares of National Health Investors to a "strong-buy" rating in a research report on Wednesday, July 2nd. Weiss Ratings reissued a "buy (b-)" rating on shares of National Health Investors in a report on Wednesday, October 8th. Finally, Wells Fargo & Company raised their target price on shares of National Health Investors from $76.00 to $80.00 and gave the stock an "equal weight" rating in a report on Wednesday, August 27th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat.com, National Health Investors has an average rating of "Buy" and a consensus price target of $84.83.
Get Our Latest Stock Analysis on National Health Investors
National Health Investors Stock Performance
Shares of NYSE:NHI opened at $73.55 on Friday. The company's 50 day simple moving average is $77.06 and its 200 day simple moving average is $74.08. The company has a debt-to-equity ratio of 0.75, a current ratio of 10.91 and a quick ratio of 10.91. National Health Investors, Inc. has a 1 year low of $65.13 and a 1 year high of $82.32. The stock has a market capitalization of $3.49 billion, a price-to-earnings ratio of 23.50, a price-to-earnings-growth ratio of 3.36 and a beta of 0.77.
National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.16 by $0.06. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The company had revenue of $70.27 million for the quarter, compared to analyst estimates of $86.46 million. During the same quarter last year, the company posted $1.18 EPS. The company's revenue for the quarter was up 6.7% compared to the same quarter last year. As a group, research analysts predict that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.
National Health Investors Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date is Tuesday, September 30th. This represents a $3.68 dividend on an annualized basis and a yield of 5.0%. This is a positive change from National Health Investors's previous quarterly dividend of $0.90. National Health Investors's dividend payout ratio is currently 117.57%.
About National Health Investors
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.